기사 (249건) 리스트형 웹진형 타일형 HanAll BiopharmaㆍJW Pharmaceutical crown 2023's top 50 gainers HanAll BiopharmaㆍJW Pharmaceutical crown 2023's top 50 gainers KoselugoㆍBosulifㆍTrimbowㆍBraftoviㆍZeposia qualify for insurance benefits starting next year KoselugoㆍBosulifㆍTrimbowㆍBraftoviㆍZeposia qualify for insurance benefits starting next year Korea to reimburse levofloxacin and doxycycline for children with Mycoplasma pneumonia Korea to reimburse levofloxacin and doxycycline for children with Mycoplasma pneumonia Zeposia, Trimbow and Koselugo are reimbursable in Korea Zeposia, Trimbow and Koselugo are reimbursable in Korea Cancer hospitalizations jump 25% in South Korea, driving a 41% surge in treatment costs Cancer hospitalizations jump 25% in South Korea, driving a 41% surge in treatment costs HER2-positive locally advanced or metastatic breast cancer treatment 'Tukysa' lands in Korea [Newsmp] The Ministry of Food and Drug Safety of South ... Institutional, foreign investors bet on KOSPI pharma stocks, retail investors remain cautious Institutional, foreign investors bet on KOSPI pharma stocks, retail investors remain cautious EnspryngㆍJemperli become reimbursable in South Korea EnspryngㆍJemperli become reimbursable in South Korea Immunotherapy, ADC, and CAR-T therapies in full swing Immunotherapy, ADC, and CAR-T therapies in full swing Big pharma oncology business thrives, MSD posts quarterly revenue of KRW 9 trillion Big pharma oncology business thrives, MSD posts quarterly revenue of KRW 9 trillion GLP-1 drugs emerge as Big Pharma's new growth engine as COVID-19 fades GLP-1 drugs emerge as Big Pharma's new growth engine as COVID-19 fades SemaglutideㆍTirzepatide boom in diabetes treatment market SemaglutideㆍTirzepatide boom in diabetes treatment market 처음처음이전이전12345678910다음다음다음끝끝
